Pulsetto

A fast-growing neurotechnology company pioneering Stress Fitness™ through vagus nerve stimulation.

Founded 2021

Lithuania 77 employees Seed Total: $900.00K Health and Wellness, Medical Devices

General Information

Company Name Pulsetto

Founded Year 2021

Location

Lithuania

Employees 77

Industries Health and Wellness, Medical Devices

Funding Stage Seed

Business Model D2C, E Commerce, Subscription Box

Revenue Model Product Sales, Subscription, Affiliate

Hiring 3 roles posted in the month to 1 Oct 2026

Social

BounceWatch is an independent company data service, not affiliated with Pulsetto. To contact Pulsetto, visit pulsetto.tech.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pulsetto compare?

A PDF of Pulsetto and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pulsetto soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Award Received Oct 01, 2026

Pulsetto was recognized as one of the World’s Top HealthTech Companies of 2026 by TIME and Statista, for outstanding performance in Medical Devices & Wearables.

Event Participation Oct 01, 2026

Pulsetto participated in the Affiliate World Conferences in Cancún, engaging attendees with its technology and Stress Fitness™ message during Q3 2026.

New Partnership Oct 01, 2026

Pulsetto announced a new partnership with SaunaSpace, expanding its approach to recovery solutions during Q3 2026.

Regulatory Approval Oct 01, 2026

Pulsetto received bioethics approval in Lithuania for a clinical trial on non-invasive bilateral vagus nerve stimulation for chronic insomnia during Q3 2026.

Get alerts when Pulsetto shows new signals

AI Insight

Bounce Watch AI

4 weeks ago

Pulsetto is strategically intensifying its market presence and customer acquisition efforts, notably demonstrated by hosting a direct-to-consumer event in New York City in September 2026. This aggressive marketing push, alongside significant website updates and ongoing hiring for three positions, indicates a dynamic period of development and a clear intent to scale. These recent activities suggest Pulsetto is actively preparing for accelerated growth and potentially a larger funding round to support its expansion.

Signal Types

Marketing Hiring Product Update Market Expansion

Strategic Labels

Market Expansion Brand Awareness Product Refinement

Next Move: Fundraising

Impact: 8/10

Ideal For: Seed-stage Wellness Tech VCs – Digital Health

About Pulsetto

Pulsetto specializes in health and wellness through neurotechnology, offering solutions for stress, anxiety, and sleep disorders. Headquartered in Vilnius, Lithuania, it provides vagus nerve stimulation devices combined with a mobile app and customer support.

Founded in 2021, Pulsetto targets individuals experiencing stress, anxiety, and sleep disorders, as well as biohackers and health enthusiasts. Its services include vagus nerve stimulation devices and a meditation app, with products available through D2C, e-commerce, and subscription models. Revenue is generated from product sales, subscriptions, and affiliate programs.

Business keywords: Neurotechnology, Stress Fitness, Vagus Nerve Stimulation, Neuromodulation, Mental Health, Wearable Tech, Anxiety Relief, Stress Resilience, Sleep Disorders, Medical Technology, Stress Relief, Heart Rate Variability, Relaxation Technology, Non-Invasive Therapy, Parasympathetic Activation

Services & Products

Vagus nerve stimulation devices

Mobile app for guided meditation and therapy

Health Savings Account (HSA) / Flexible Spending Account (FSA) payment options

Customer support

Target Customers

Individuals experiencing stress or anxiety People with sleep disorders Biohackers Mental health enthusiasts Health-conscious individuals Athletes seeking mental resilience

Funding Rounds & Investors (2)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Seed	€400.00K	-		01 Feb 2025
Seed	€500.00K	1	Kilo Health	01 Apr 2022

Latest News

View All

Bilateral Vagus Nerve Wearables: Pulsetto FIT X Personalizes Dual-Channel Nerve…

Trend Hunter Sep 18, 2026

Pulsetto Introduces FIT X, the Next Generation of Its Stress Fitness Platform

Yahoo Finance Sep 17, 2026

Pulsetto Revenue 2025: $4.1M Est. ARR

GetLatka Sep 10, 2026

NBA Players Turn To Stress Fitness For Recovery With Pulsetto

PR Newswire Jul 27, 2026

Bootstrapped to €500M: the story behind Kilo's quiet rise — and its next billion-dollar bet

Tech Mar 04, 2026

From restless nights to better sleep: 10 European startups transforming how we rest, recover, and re... — Eu-startups

From restless nights to better sleep: 10 European startups transforming how we rest, recover, and recharge

Eu-startups Aug 21, 2025

Pulsetto Alternatives & Competitors

View All Alternatives

Pulsetto vs

Vagustim Turkey

Vagustim develops innovative vagus activation technology to support overall well-being.

12 employees

Health Care, Health and Wellness

Compare Pulsetto vs Vagustim

Pulsetto vs

Neuronetics, Inc. United States

Non-drug, safe, effective treatment for depression and other mental health conditions.

Post-IPO Debt

220 employees

Biotechnology, Health Care

Compare Pulsetto vs Neuronetics, Inc.

Pulsetto vs

Nexstim Finland

We enable personalized and effective therapies and diagnostics for challenging brain diseases and di...

Post-IPO Debt

52 employees

Biotechnology, Health Care

View all alternatives

FAQ About Pulsetto

A fast-growing neurotechnology company pioneering Stress Fitness™ through vagus nerve stimulation.

Pulsetto was founded in 2021.

Pulsetto is headquartered in Lithuania.

Pulsetto operates in Health and Wellness and Medical Devices. Its work centres on Neurotechnology, Stress Fitness, Vagus Nerve Stimulation and Neuromodulation. Its customers include Individuals experiencing stress or anxiety, People with sleep disorders and Biohackers.

Pulsetto has a D2C, E Commerce and Subscription Box business model. Its revenue comes from Product Sales, Subscription and Affiliate.

Pulsetto has approximately 77 employees.

Pulsetto has completed 2 funding rounds, raising a total of $900.00K. The latest funding stage is Seed.

Pulsetto offers: Vagus nerve stimulation devices, Mobile app for guided meditation and therapy, Health Savings Account (HSA) / Flexible Spending Account (FSA) payment options, Customer support.

Top alternatives and competitors to Pulsetto include Vagustim, Neuronetics, Inc., Nexstim, Cara Care. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Pulsetto and Vagustim are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pulsetto, https://bouncewatch.com/company/pulsetto, updated 1 October 2026. When citing, please name BounceWatch and link this page.

Pulsetto

General Information

Discover More

What changed at Pulsetto recently?

AI Insight

About Pulsetto

Services & Products

Target Customers

Funding Rounds & Investors (2)

Latest News

Pulsetto Alternatives & Competitors

FAQ About Pulsetto